Nielsen TO - Search Results

1

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.

Hudeček J, Voorwerk L, van Seijen M, Nederlof I, de Maaker M, van den Berg J, van de Vijver KK, Sikorska K, Adams S, Demaria S, Viale G, Nielsen TO, Badve SS, Michiels S, Symmans WF, Sotiriou C, Rimm DL, Hewitt SM, Denkert C, Loibl S, Loi S, Bartlett JMS, Pruneri G, Dillon DA, Cheang MCU, Tutt A, Hall JA, Kos Z, Salgado R, Kok M, Horlings HM; International Immuno-Oncology Biomarker Working Group. Hudeček J, et al. Among authors: nielsen to. NPJ Breast Cancer. 2020 May 12;6:15. doi: 10.1038/s41523-020-0155-1. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 32436923 Free PMC article. Review.

2

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Nielsen TO, et al. Clin Cancer Res. 2004 Aug 15;10(16):5367-74. doi: 10.1158/1078-0432.CCR-04-0220. Clin Cancer Res. 2004. PMID: 15328174

3

Nuclear beta-catenin in mesenchymal tumors.

Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB, Nielsen TO. Ng TL, et al. Among authors: nielsen to. Mod Pathol. 2005 Jan;18(1):68-74. doi: 10.1038/modpathol.3800272. Mod Pathol. 2005. PMID: 15375433 Free article.

4

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.

Makretsov NA, Huntsman DG, Nielsen TO, Yorida E, Peacock M, Cheang MC, Dunn SE, Hayes M, van de Rijn M, Bajdik C, Gilks CB. Makretsov NA, et al. Among authors: nielsen to. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6143-51. doi: 10.1158/1078-0432.CCR-04-0429. Clin Cancer Res. 2004. PMID: 15448001

5

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.

Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, Cheang M, Turbin D, Gelmon K, Huntsman DG. Wiseman SM, et al. Among authors: nielsen to. Cancer. 2005 May 1;103(9):1770-7. doi: 10.1002/cncr.20970. Cancer. 2005. PMID: 15770691 Free article.

6

Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.

Terry J, Barry TS, Horsman DE, Hsu FD, Gown AM, Huntsman DG, Nielsen TO. Terry J, et al. Among authors: nielsen to. Diagn Mol Pathol. 2005 Jun;14(2):77-82. doi: 10.1097/01.pas.0000155021.80213.c9. Diagn Mol Pathol. 2005. PMID: 15905690

7

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

Turbin DA, Cheang MC, Bajdik CD, Gelmon KA, Yorida E, De Luca A, Nielsen TO, Huntsman DG, Gilks CB. Turbin DA, et al. Among authors: nielsen to. Mod Pathol. 2006 Jan;19(1):69-74. doi: 10.1038/modpathol.3800484. Mod Pathol. 2006. PMID: 16258514 Free article.

8

Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.

Cheang MC, Treaba DO, Speers CH, Olivotto IA, Bajdik CD, Chia SK, Goldstein LC, Gelmon KA, Huntsman D, Gilks CB, Nielsen TO, Gown AM. Cheang MC, et al. Among authors: nielsen to. J Clin Oncol. 2006 Dec 20;24(36):5637-44. doi: 10.1200/JCO.2005.05.4155. Epub 2006 Nov 20. J Clin Oncol. 2006. PMID: 17116944

9

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.

Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO, Foulkes WD. Tischkowitz M, et al. Among authors: nielsen to. BMC Cancer. 2007 Jul 24;7:134. doi: 10.1186/1471-2407-7-134. BMC Cancer. 2007. PMID: 17650314 Free PMC article.

10

FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H. Badve S, et al. Among authors: nielsen to. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122. Clin Cancer Res. 2007. PMID: 17671124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page